Published in
Dove Press, Breast Cancer: Targets and Therapy, (Volume 11), p. 29-42, 2018
DOI: 10.2147/bctt.s179750
Links
Tools
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution
Journal article published in 2018 by
Silvia Antolín,
Benigno Acea,
Luis Albaina,
Ángel Concha,
Paz Santiago,
Tomás García-Caballero,
Joaquin Mosquera,
José Ramón Varela,
Rafaela Soler,
Lourdes Calvo 
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 